Quidel QuickVue AdenoViral Conjunctivitis Test (10 Tests)

Acute conjunctivitis – more commonly known as “pink eye” – affects nearly 6.9 million people in the United States every year.¹ Approximately 1 in 4 patients with acute conjunctivitis have confirmed adenoviral conjunctivitis.^2,3 QuickVue Adenoviral conjunctivitis Test is the first and only CLIA-waived, point-of-care test that detects all known serotypes of adenoviral conjunctivitis.

Early and accurate diagnosis of pink eye may prevent serious consequences including morbidity. Significant overlap exists in the clinical signs and symptoms of acute conjunctivitis and misdiagnosis by eye care professionals occurs in approximately 50% of conjunctivitis cases.⁴ With QuickVue Adenoviral conjunctivitis Test you can make a rapid, accurate diagnosis before the patient leaves your office.

By implementing QuickVue Adenoviral conjunctivits Test into your practice, you can:

• Isolate and manage contagious patients
• Prevent the spread of infection
• Reduce unnecessary antibiotic prescriptions
• Reduce potential ocular allergies and toxicities associated with unnecessary antibiotic use
• Help prevent antibiotic resistance

Recommended CPT® Code
The assigned CPT (Current Procedural Terminology) code for the QuickVue Adenoviral conjunctivitis Test is 87809.

For Medicare and Medicaid claims, add a QW modifier to indicate test is CLIA waived.

Given that payers have varied policies, it is possible that certain payers have different coding requirements. If performing bilateral testing (testing both eyes), you may need to add one of the following modifiers to denote that each eye was tested:

87809QW-RT, 87809QW-LT

87809QW, 87809QW-59 (-59 modifier indicates that it is a distinct procedural service)

87809QW-50 with a single unit of service (-50 modifier indicates that it is a bilateral procedure)

Note: The QuickVue Adenoviral conjunctivitis Test is a single use item. Bilateral testing requires two separate tests.

Quidel strongly recommends that providers contact their own regional payers to determine appropriate coding and
charge or payment levels prior to submitting claims. For the Medicare Clinical Laboratory Fee Schedule, visit
https://www.cms.gov.

For information on additional eye health products, visit QuidelEyeHealth.com.

References

¹ Thomson Reuters Medstat Marketscan Data, 2005.

² Sambursky R, Trattler W, Tauber S, et al. Sensitivity and specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis. JAMA Ophthalmol. 2013;131:17-22.

³ Sambursky R, Tauber S, Schirra F, et al. The RPS Adeno Detector for diagnosing adenoviral conjunctivitis. Ophthalmology. 2006 Oct;113(10):1758-64.

⁴ O’Brien TP, Jeng BH, McDonald M, et al. Acute Conjunctivitis: truth and misconceptions. Curr Med Res Opin 2009; 25(8):1953-1961